Essential Oil Composition for Reducing Respiratory Epithelial Thickness
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Particulate matter, particularly PM2.5, exacerbates respiratory diseases by inducing oxidative stress and inflammatory responses, leading to conditions like asthma and chronic obstructive pulmonary disease, for which current solutions are inadequate in providing effective prevention and treatment.
Innovation Solution
A pharmaceutical composition comprising essential oil extracts of mint, Asarum sieboldi, and fir leaves, administered via inhalation or intranasally, in specific volume ratios to reduce epithelial thickness, collagen accumulation, and inflammatory cytokine expression in lung tissue.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for respiratory diseases caused by particulate matter, then general symptom relief may be achieved, but effective prevention and treatment of oxidative stress and inflammatory responses is insufficient
Solution Approach 1:
The patent uses a composite formulation containing multiple essential oil extracts (mint, Asarum sieboldi, and fir leaves) combined in specific ratios. This composite approach synergistically addresses multiple pathological mechanisms simultaneously - mint provides anti-inflammatory and bronchodilatory effects, Asarum sieboldi contributes antioxidant and anti-allergic properties, and fir leaves provide expectorant and anti-inflammatory actions. The combination creates a more comprehensive and reliable treatment than single-agent therapies.
Solution Approach 2:
The patent optimizes specific parameters including the volume ratios of different essential oil extracts (mint: Asarum sieboldi: fir leaves in ratios within 3:2:1 to 5:3:2), extraction conditions (solvent type, temperature, time), and administration dosage. These parameter optimizations ensure maximum efficacy in reducing oxidative stress markers and inflammatory cytokines while minimizing side effects, thereby improving treatment reliability.
2Ease of operation
If essential oil extracts are administered via inhalation or intranasal routes, then direct delivery to respiratory tissues is achieved, but formulation complexity increases
Solution Approach 1:
The patent employs appropriate carriers and excipients as intermediaries to facilitate the delivery of essential oil extracts through inhalation or intranasal routes. These intermediaries include pharmaceutically acceptable vehicles that ensure proper aerosolization, stability, and mucosal penetration while maintaining the therapeutic integrity of the active ingredients. This approach simplifies the overall administration process despite the complex active ingredient composition.
Solution Approach 2:
For inhalation administration, the patent utilizes pneumatic principles through nebulizers or aerosol generation systems that convert liquid formulations into fine mist particles suitable for respiratory tract deposition. The formulation is designed to work with these pneumatic delivery devices, optimizing particle size distribution and airflow characteristics to achieve effective drug delivery to target tissues without requiring complex mechanical systems.
3Strength
If the composition reduces epithelial thickness and collagen accumulation, then respiratory function is improved, but the underlying inflammatory response must be effectively controlled
Solution Approach 1:
The patent employs essential oil components with proven anti-inflammatory and anti-fibrotic properties that act preemptively to prevent excessive epithelial thickening and collagen deposition. Mint oil provides bronchodilatory and anti-inflammatory effects that prevent airway remodeling, while Asarum sieboldi and fir leaf extracts inhibit fibroblast activation and collagen synthesis. This preliminary anti-action approach addresses the root inflammatory cause before structural damage occurs, thereby improving respiratory function more effectively.
Solution Approach 2:
The patent converts the harmful effects of particulate matter-induced inflammation into beneficial therapeutic outcomes by using the same inflammatory pathways targeted by the essential oils. The formulation modulates cytokine signaling to reduce pathological inflammation while preserving protective immune responses, and transforms fibrotic responses into controlled tissue repair processes, thereby improving respiratory function through controlled modulation rather than complete suppression.
Data Source
AI summary
The present invention relates to a composition for treating respiratory diseases due to particulate matter, wherein the composition contains, as active ingredients, essential oil extracts of mint, Asarum sieboldi, and fir leaves. A composite obtained by mixing essential oil extracts of mint, Asarum sieboldi, and fir leaves according to the present invention exhibits the effect of relieving the symptoms of chronic respiratory diseases caused by ovalbumin and particulate matter in an animal model, and thus can be effectively used to directly treat respiratory diseases due to particulate matter.